Davenben Enterprises Corp. Pharmaceutical Import Profile — Philippines (DGFT 2022–2026)

Name: Davenben Enterprises Corp. Pharmaceutical Import Records from India — 2 Products, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Davenben Enterprises Corp. — Pharmaceutical Importer Profile (2026) | 2 Products, $1.1M Trade | TransData Nexus

Davenben Enterprises Corp.

Pharmaceutical Importer · Philippines · Ayurvedic & Herbal Products Focus · $1.1M Total Trade · DGFT Verified

Davenben Enterprises Corp. is a pharmaceutical importer based in Philippines with a total trade value of $1.1M across 2 products in 1 therapeutic categories. Based on 23 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Davenben Enterprises Corp. sources from 1 verified Indian supplier, with Lumen Marketing Company accounting for 100.0% of imports.

Davenben Enterprises Corp. — Import Portfolio & Supplier Network

Davenben Enterprises Corp. import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Davenben Enterprises Corp.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Lumen Marketing Company	$1.4M	30	100.0%

Davenben Enterprises Corp. sources from 1 verified Indian supplier across 3 distinct formulations. The sourcing is highly concentrated — Lumen Marketing Company accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Davenben Enterprises Corp. Import?

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ayurvedic	Ayurvedic & Herbal Products	$950.0K	19	4.1%	3
2	Extract	Ayurvedic & Herbal Products	$200.0K	4	1.6%	5

Davenben Enterprises Corp. imports 2 pharmaceutical products across 1 categories into Philippines totaling $1.1M.

Davenben Enterprises Corp. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Davenben Enterprises Corp. is a pharmaceutical importer and distributor based in Pasig City, Philippines. The company operates as a wholesaler, sourcing finished pharmaceutical formulations from international suppliers for distribution within the Philippine market. Their product portfolio includes Ayurvedic and herbal products, with a notable emphasis on formulations such as Memo Plus Gold, which contains Bacopa Monnieri extract.

The company's headquarters are located at Unit 1907, 19/F Jollibee Plaza, F. Ortigas Jr. Avenue, Ortigas Center, 1605 Pasig City, Philippines. Davenben Enterprises Corp. maintains direct contact with suppliers and clients, facilitating the importation and distribution of pharmaceutical products across the country.

2Distribution Network

Davenben Enterprises Corp. operates its distribution network from its headquarters in Pasig City, strategically situated in the heart of Metro Manila. This central location enables efficient logistics and access to major transportation routes, facilitating the timely distribution of pharmaceutical products throughout the Philippines. While specific details about additional warehouse locations or logistics capabilities are not publicly disclosed, the company's central office serves as the primary hub for its distribution operations.

3Industry Role

In the Philippine pharmaceutical supply chain, Davenben Enterprises Corp. functions primarily as a wholesaler and distributor. By importing finished pharmaceutical formulations from international suppliers, the company plays a crucial role in making these products available to local pharmacies, hospitals, and healthcare providers. Their focus on Ayurvedic and herbal products indicates a specialization in alternative medicine, catering to a niche market segment within the broader pharmaceutical industry.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Davenben Enterprises Corp.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Davenben Enterprises Corp. exhibits a high degree of supplier concentration, sourcing all of its pharmaceutical imports from a single supplier, Lumen Marketing Company. This exclusive sourcing arrangement suggests a strategic partnership, potentially offering benefits such as favorable pricing, consistent product quality, and streamlined logistics. However, this dependency also introduces risks; any disruptions in Lumen Marketing Company's operations—such as production delays, quality control issues, or regulatory challenges—could significantly impact Davenben's ability to meet market demand. The absence of alternative suppliers may limit the company's flexibility in responding to supply chain disruptions.

2Supply Chain Resilience

The resilience of Davenben Enterprises Corp.'s supply chain is closely tied to the stability and reliability of Lumen Marketing Company. Given the exclusive sourcing arrangement, Davenben's supply chain is vulnerable to any operational challenges faced by Lumen, including production delays, quality control issues, or regulatory compliance problems. The lack of backup suppliers or alternative sourcing options further exacerbates this vulnerability. To enhance supply chain resilience, Davenben may consider diversifying its supplier base and establishing contingency plans to mitigate potential disruptions.

Importing Pharmaceuticals into Philippines — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Philippines

1Regulatory Authority & Framework

In the Philippines, the Food and Drug Administration (FDA) is the primary regulatory body overseeing the importation, registration, and distribution of pharmaceutical products. The FDA operates under the Department of Health (DOH) and is responsible for ensuring the safety, efficacy, and quality of drugs entering the country. Key legislation governing pharmaceutical imports includes the FDA Act of 2009 (Republic Act No. 9711) and the Food, Drugs, and Devices Act (Republic Act No. 3720). These laws establish the regulatory framework for drug registration, importation, and market surveillance. (respicio.ph)

2Import Licensing & GMP

To import pharmaceutical products into the Philippines, companies must secure a License to Operate (LTO) from the FDA. This license authorizes the holder to engage in the importation and distribution of drugs and medicines. Additionally, imported pharmaceutical products must be registered with the FDA, ensuring they meet the required safety, efficacy, and quality standards. The FDA recognizes Good Manufacturing Practice (GMP) certificates from various international standards, including EU GMP, WHO GMP, and PIC/S, facilitating the importation of products manufactured under these recognized standards. (respicio.ph)

Quality & Labeling

Davenben Enterprises Corp. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Davenben Enterprises Corp.'s focus on Ayurvedic and herbal pharmaceutical products aligns with the growing consumer interest in natural and alternative medicine in the Philippines. Products like Memo Plus Gold, which contains Bacopa Monnieri extract, cater to consumers seeking cognitive enhancement and stress relief. The market demand for such products is driven by increasing health consciousness and a preference for natural remedies. By specializing in this niche, Davenben can leverage its expertise to build a strong brand presence and customer loyalty.

2Sourcing Profile

Davenben Enterprises Corp. employs a sourcing strategy that relies exclusively on Lumen Marketing Company for its pharmaceutical imports. This approach suggests a focus on product consistency and quality, as Lumen provides specific formulations like Memo Plus Gold. The exclusive sourcing arrangement indicates a strategic partnership aimed at ensuring a steady supply of products that meet Davenben's standards. However, this strategy also exposes the company to risks associated with supplier dependency.

3Market Positioning

By importing and distributing Ayurvedic and herbal pharmaceutical products, Davenben Enterprises Corp. serves a segment of the Philippine market that includes retail pharmacies, health and wellness stores, and consumers seeking alternative medicine options. The company's focus on natural and herbal products positions it to cater to the growing demand for holistic health solutions, differentiating it from competitors that offer conventional pharmaceutical products.

Seller's Guide — How to Become a Supplier to Davenben Enterprises Corp.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

The exclusive sourcing arrangement between Davenben Enterprises Corp. and Lumen Marketing Company presents an opportunity for other Indian pharmaceutical exporters to introduce alternative products to Davenben. By offering unique formulations or competitive pricing, new suppliers can position themselves as viable options for Davenben, potentially reducing the company's reliance on a single supplier and enhancing its supply chain resilience. Additionally, diversifying the supplier base can provide Davenben with access to a broader range of products, catering to a wider consumer base.

2Requirements & Qualifications

Indian exporters seeking to supply pharmaceutical products to Davenben Enterprises Corp. and the Philippine market must ensure that their products are registered with the Philippine FDA and comply with the country's GMP standards. Obtaining an FDA License to Operate (LTO) is essential for importers, and products must meet the FDA's safety, efficacy, and quality requirements. Additionally, products should adhere to labeling requirements, including the use of the English language and the inclusion of specific product information. (respicio.ph)

3How to Approach

Frequently Asked Questions — Davenben Enterprises Corp.

What products does Davenben Enterprises Corp. import from India?

Davenben Enterprises Corp. imports 2 pharmaceutical products across 1 categories. Top imports: Ayurvedic ($950.0K), Extract ($200.0K).

Who supplies pharmaceuticals to Davenben Enterprises Corp. from India?

Davenben Enterprises Corp. sources from 1 verified Indian suppliers. The primary supplier is Lumen Marketing Company (100.0% of imports, $1.4M).

What is Davenben Enterprises Corp.'s total pharmaceutical import value?

Davenben Enterprises Corp.'s total pharmaceutical import value from India is $1.1M, based on 23 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Davenben Enterprises Corp. focus on?

Davenben Enterprises Corp. imports across 1 categories. The largest: Ayurvedic & Herbal Products (100.0%).

Get Full Davenben Enterprises Corp. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Formulation	Value	Ships
Memo plus gold ayurvedic capsules	$1.3M	28
Memo plus gold ayurvedic capsules	$50.0K	1
Memo plus gold ayurvedic capsules bacopa monnieriextract 125 MG	$50.0K	1